Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 121 | 2024 | 21207 | 5.300 |
Why?
|
Genetic Heterogeneity | 10 | 2020 | 736 | 2.740 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 15 | 2023 | 934 | 2.570 |
Why?
|
Carcinoma, Ductal, Breast | 16 | 2023 | 1099 | 2.550 |
Why?
|
Drug Resistance, Neoplasm | 16 | 2024 | 5341 | 2.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 44 | 2024 | 8648 | 2.170 |
Why?
|
Mammary Glands, Human | 14 | 2019 | 202 | 2.150 |
Why?
|
Neoplasms | 50 | 2023 | 22371 | 2.030 |
Why?
|
Mammary Glands, Animal | 11 | 2024 | 273 | 1.970 |
Why?
|
Epithelial Cells | 30 | 2021 | 3703 | 1.720 |
Why?
|
Neoplastic Stem Cells | 16 | 2014 | 1351 | 1.700 |
Why?
|
Inflammatory Breast Neoplasms | 3 | 2024 | 150 | 1.690 |
Why?
|
Breast | 20 | 2023 | 1976 | 1.660 |
Why?
|
Gene Expression Profiling | 37 | 2019 | 9540 | 1.580 |
Why?
|
Epigenesis, Genetic | 25 | 2024 | 3833 | 1.580 |
Why?
|
Stromal Cells | 12 | 2024 | 1337 | 1.360 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 9 | 2019 | 317 | 1.340 |
Why?
|
Neoplasm Metastasis | 14 | 2019 | 4913 | 1.300 |
Why?
|
Receptor, erbB-2 | 11 | 2024 | 2603 | 1.280 |
Why?
|
Tumor Microenvironment | 13 | 2021 | 3948 | 1.210 |
Why?
|
Cell Line, Tumor | 43 | 2024 | 17142 | 1.170 |
Why?
|
Nuclear Proteins | 15 | 2023 | 5804 | 1.120 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 168 | 1.120 |
Why?
|
Mutation | 36 | 2021 | 30237 | 1.100 |
Why?
|
Transcription Factors | 16 | 2024 | 12171 | 1.070 |
Why?
|
Clone Cells | 6 | 2020 | 1670 | 1.010 |
Why?
|
Cell Transformation, Neoplastic | 20 | 2024 | 2846 | 1.010 |
Why?
|
DNA Methylation | 16 | 2015 | 4428 | 1.010 |
Why?
|
DNA, Neoplasm | 9 | 2020 | 1744 | 0.970 |
Why?
|
Tumor Suppressor Proteins | 17 | 2019 | 2810 | 0.960 |
Why?
|
Neoplasm Proteins | 19 | 2024 | 3604 | 0.920 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 6 | 2024 | 905 | 0.900 |
Why?
|
Stem Cells | 11 | 2023 | 3538 | 0.900 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2024 | 139 | 0.890 |
Why?
|
Paclitaxel | 4 | 2024 | 1733 | 0.880 |
Why?
|
Retinoblastoma-Binding Protein 2 | 2 | 2024 | 35 | 0.870 |
Why?
|
BRCA1 Protein | 5 | 2019 | 1155 | 0.840 |
Why?
|
Glycocalyx | 1 | 2024 | 99 | 0.840 |
Why?
|
Cell Lineage | 6 | 2018 | 2575 | 0.790 |
Why?
|
Repressor Proteins | 6 | 2018 | 2982 | 0.770 |
Why?
|
Tumor Escape | 2 | 2021 | 372 | 0.760 |
Why?
|
Carcinoma in Situ | 9 | 2010 | 788 | 0.760 |
Why?
|
Models, Biological | 18 | 2021 | 9497 | 0.760 |
Why?
|
Histone Demethylases | 1 | 2024 | 328 | 0.750 |
Why?
|
Azepines | 3 | 2020 | 329 | 0.740 |
Why?
|
Female | 136 | 2024 | 397187 | 0.730 |
Why?
|
Carcinoma, Ductal | 4 | 2010 | 97 | 0.730 |
Why?
|
Oncogenes | 6 | 2014 | 1234 | 0.730 |
Why?
|
Humans | 207 | 2024 | 768171 | 0.720 |
Why?
|
Phosphatidylinositol 3-Kinases | 10 | 2024 | 2885 | 0.710 |
Why?
|
Genes, Tumor Suppressor | 13 | 2008 | 1062 | 0.690 |
Why?
|
Animals | 82 | 2024 | 169285 | 0.680 |
Why?
|
Disease Progression | 28 | 2023 | 13668 | 0.680 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2020 | 354 | 0.680 |
Why?
|
Genes, erbB-2 | 3 | 2015 | 162 | 0.670 |
Why?
|
Signal Transduction | 31 | 2024 | 23648 | 0.630 |
Why?
|
Up-Regulation | 4 | 2024 | 4149 | 0.630 |
Why?
|
Neoplasm Invasiveness | 18 | 2017 | 3620 | 0.630 |
Why?
|
Quinolines | 1 | 2024 | 772 | 0.620 |
Why?
|
Nitriles | 1 | 2024 | 980 | 0.620 |
Why?
|
Genetic Variation | 5 | 2017 | 6610 | 0.610 |
Why?
|
Estrogen Receptor alpha | 4 | 2019 | 581 | 0.610 |
Why?
|
Cyclin-Dependent Kinase 4 | 5 | 2020 | 565 | 0.590 |
Why?
|
Triazoles | 3 | 2020 | 904 | 0.580 |
Why?
|
DNA-Binding Proteins | 5 | 2024 | 9617 | 0.580 |
Why?
|
Fibroblasts | 9 | 2021 | 4178 | 0.570 |
Why?
|
Cell Proliferation | 21 | 2024 | 10478 | 0.570 |
Why?
|
Cyclins | 16 | 2004 | 606 | 0.570 |
Why?
|
Proteins | 6 | 2020 | 6009 | 0.570 |
Why?
|
Brain Neoplasms | 4 | 2024 | 9118 | 0.560 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2019 | 3612 | 0.560 |
Why?
|
BRCA2 Protein | 2 | 2019 | 802 | 0.540 |
Why?
|
Immunotherapy | 6 | 2023 | 4754 | 0.540 |
Why?
|
Homeodomain Proteins | 4 | 2023 | 2430 | 0.540 |
Why?
|
Single-Cell Analysis | 4 | 2019 | 2540 | 0.520 |
Why?
|
Estrogens | 6 | 2023 | 1536 | 0.520 |
Why?
|
Oligonucleotide Array Sequence Analysis | 11 | 2013 | 3806 | 0.520 |
Why?
|
Mice | 45 | 2024 | 82049 | 0.490 |
Why?
|
Histones | 7 | 2024 | 2601 | 0.490 |
Why?
|
Cell Differentiation | 16 | 2019 | 11677 | 0.490 |
Why?
|
Pyrazoles | 2 | 2024 | 2028 | 0.480 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2024 | 506 | 0.480 |
Why?
|
RNA, Neoplasm | 5 | 2013 | 749 | 0.480 |
Why?
|
Calcium-Binding Proteins | 5 | 2008 | 1083 | 0.470 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2012 | 2956 | 0.450 |
Why?
|
Wnt1 Protein | 1 | 2014 | 123 | 0.450 |
Why?
|
Cell Communication | 7 | 2024 | 1660 | 0.440 |
Why?
|
Cyclin-Dependent Kinases | 11 | 1996 | 663 | 0.430 |
Why?
|
STAT3 Transcription Factor | 2 | 2023 | 874 | 0.430 |
Why?
|
Transforming Growth Factor beta | 9 | 2014 | 2004 | 0.410 |
Why?
|
Cytokines | 7 | 2005 | 7452 | 0.400 |
Why?
|
Promoter Regions, Genetic | 7 | 2024 | 5797 | 0.400 |
Why?
|
Cell Cycle | 14 | 2017 | 2934 | 0.390 |
Why?
|
Phenotype | 18 | 2020 | 16726 | 0.390 |
Why?
|
Cell Cycle Proteins | 10 | 2022 | 3445 | 0.380 |
Why?
|
Pyrimidines | 1 | 2024 | 3048 | 0.380 |
Why?
|
Rats, Inbred ACI | 2 | 2022 | 34 | 0.380 |
Why?
|
Gene Library | 10 | 2010 | 1064 | 0.370 |
Why?
|
Genome, Human | 8 | 2016 | 4446 | 0.370 |
Why?
|
Tumor Cells, Cultured | 18 | 2013 | 6124 | 0.370 |
Why?
|
Apoptosis | 10 | 2018 | 9527 | 0.370 |
Why?
|
Microchemistry | 1 | 2010 | 55 | 0.360 |
Why?
|
Alternative Splicing | 2 | 2015 | 1105 | 0.350 |
Why?
|
Gene Amplification | 3 | 2014 | 1095 | 0.350 |
Why?
|
RNA, Antisense | 1 | 2010 | 136 | 0.350 |
Why?
|
Genomics | 6 | 2020 | 5926 | 0.350 |
Why?
|
Transcription, Genetic | 6 | 2018 | 7609 | 0.340 |
Why?
|
CDC2-CDC28 Kinases | 6 | 1995 | 111 | 0.340 |
Why?
|
Parity | 1 | 2013 | 931 | 0.340 |
Why?
|
Plasma | 1 | 2013 | 585 | 0.340 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2830 | 0.340 |
Why?
|
Gene Expression | 11 | 2017 | 7601 | 0.330 |
Why?
|
Genes, BRCA1 | 4 | 2014 | 755 | 0.330 |
Why?
|
Cyclooxygenase 2 | 2 | 2009 | 598 | 0.330 |
Why?
|
Selection, Genetic | 1 | 2014 | 877 | 0.330 |
Why?
|
Patient Selection | 2 | 2019 | 4260 | 0.320 |
Why?
|
Chemokines, CXC | 2 | 2008 | 420 | 0.320 |
Why?
|
Antineoplastic Agents | 9 | 2020 | 13677 | 0.320 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3772 | 0.310 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2015 | 2433 | 0.310 |
Why?
|
Adult Stem Cells | 3 | 2011 | 221 | 0.310 |
Why?
|
Aging | 2 | 2024 | 8743 | 0.300 |
Why?
|
Karyotyping | 3 | 2013 | 1177 | 0.300 |
Why?
|
Janus Kinase 2 | 1 | 2011 | 561 | 0.300 |
Why?
|
Tamoxifen | 5 | 2015 | 966 | 0.290 |
Why?
|
Cathepsins | 1 | 2008 | 243 | 0.290 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 633 | 0.290 |
Why?
|
Rats | 5 | 2024 | 23782 | 0.280 |
Why?
|
Epithelium | 8 | 2013 | 1607 | 0.280 |
Why?
|
Cell Shape | 3 | 2015 | 371 | 0.280 |
Why?
|
Genes, Neoplasm | 3 | 2010 | 371 | 0.270 |
Why?
|
Macrophages | 2 | 2021 | 5802 | 0.270 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2006 | 44 | 0.270 |
Why?
|
Mesoderm | 2 | 2009 | 679 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2013 | 2459 | 0.270 |
Why?
|
Neutrophils | 1 | 2019 | 3786 | 0.270 |
Why?
|
Carcinoma | 5 | 2022 | 2332 | 0.260 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2007 | 123 | 0.260 |
Why?
|
Neoplasm Transplantation | 4 | 2021 | 2014 | 0.260 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1120 | 0.260 |
Why?
|
Rats, Sprague-Dawley | 3 | 2022 | 8142 | 0.260 |
Why?
|
S100 Proteins | 6 | 2012 | 216 | 0.260 |
Why?
|
NF-kappa B | 5 | 2024 | 2494 | 0.250 |
Why?
|
Genes, p53 | 3 | 2013 | 714 | 0.250 |
Why?
|
Methylnitrosourea | 1 | 2024 | 30 | 0.240 |
Why?
|
RNA, Small Interfering | 5 | 2018 | 3428 | 0.240 |
Why?
|
Extracellular Matrix | 2 | 2010 | 1738 | 0.240 |
Why?
|
Carcinoma, Lobular | 3 | 2008 | 480 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 7 | 2019 | 18065 | 0.240 |
Why?
|
DNA Damage | 5 | 2022 | 2469 | 0.230 |
Why?
|
Colorectal Neoplasms | 9 | 2013 | 6975 | 0.230 |
Why?
|
Microtubule-Associated Proteins | 6 | 1996 | 1074 | 0.230 |
Why?
|
Receptors, Estrogen | 6 | 2019 | 2253 | 0.230 |
Why?
|
Sequence Analysis, DNA | 5 | 2010 | 4786 | 0.230 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 9 | 2013 | 4585 | 0.230 |
Why?
|
Fluorescent Antibody Technique | 4 | 2019 | 2474 | 0.230 |
Why?
|
Neoplastic Processes | 1 | 2023 | 36 | 0.230 |
Why?
|
Genes, BRCA2 | 2 | 2004 | 593 | 0.220 |
Why?
|
Cell Division | 5 | 2004 | 4477 | 0.220 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2568 | 0.220 |
Why?
|
G1 Phase | 5 | 1996 | 403 | 0.210 |
Why?
|
Disease Models, Animal | 12 | 2024 | 18349 | 0.210 |
Why?
|
Biomedical Research | 3 | 2016 | 3463 | 0.210 |
Why?
|
Antigens, CD | 3 | 2010 | 4035 | 0.210 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2015 | 2521 | 0.210 |
Why?
|
Cell Movement | 8 | 2017 | 5213 | 0.210 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4058 | 0.200 |
Why?
|
Chromosome Aberrations | 2 | 2010 | 1778 | 0.200 |
Why?
|
Chromatin | 4 | 2019 | 2981 | 0.200 |
Why?
|
Coculture Techniques | 2 | 2024 | 1344 | 0.200 |
Why?
|
Pluripotent Stem Cells | 1 | 2009 | 809 | 0.200 |
Why?
|
Enzyme Activation | 9 | 2015 | 3590 | 0.190 |
Why?
|
Prognosis | 10 | 2019 | 30009 | 0.190 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1250 | 0.190 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 3 | 2022 | 165 | 0.190 |
Why?
|
Histone Acetyltransferases | 1 | 2023 | 335 | 0.190 |
Why?
|
Estrogen Antagonists | 1 | 2002 | 151 | 0.190 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 308 | 0.190 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2907 | 0.190 |
Why?
|
Cell Growth Processes | 3 | 2014 | 381 | 0.190 |
Why?
|
Cell Fusion | 3 | 2015 | 294 | 0.190 |
Why?
|
T-Lymphocytes | 4 | 2024 | 10266 | 0.190 |
Why?
|
Arylsulfotransferase | 1 | 2000 | 27 | 0.190 |
Why?
|
Mucin-1 | 2 | 2024 | 537 | 0.180 |
Why?
|
Melanoma | 1 | 2019 | 5706 | 0.180 |
Why?
|
Hormones | 2 | 2022 | 866 | 0.180 |
Why?
|
Lupus Nephritis | 1 | 2024 | 327 | 0.180 |
Why?
|
RNA, Messenger | 12 | 2024 | 12801 | 0.180 |
Why?
|
Molecular Sequence Data | 14 | 2015 | 17623 | 0.170 |
Why?
|
Gene Expression Regulation | 5 | 2015 | 11930 | 0.170 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2003 | 2748 | 0.170 |
Why?
|
Epigenomics | 3 | 2015 | 960 | 0.170 |
Why?
|
Podocytes | 1 | 2024 | 403 | 0.170 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 812 | 0.170 |
Why?
|
Interleukin-6 | 3 | 2024 | 3229 | 0.170 |
Why?
|
Pregnancy | 7 | 2019 | 30255 | 0.170 |
Why?
|
Ploidies | 1 | 2020 | 287 | 0.170 |
Why?
|
Transfection | 7 | 2017 | 5756 | 0.170 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2024 | 701 | 0.170 |
Why?
|
Mesenchymal Stem Cells | 3 | 2019 | 1673 | 0.170 |
Why?
|
Endocrine Cells | 1 | 2019 | 9 | 0.170 |
Why?
|
Transcriptional Activation | 3 | 2022 | 1750 | 0.160 |
Why?
|
Osteoprotegerin | 1 | 2020 | 179 | 0.160 |
Why?
|
Integrin alpha1 | 1 | 2019 | 13 | 0.160 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2015 | 757 | 0.160 |
Why?
|
Inflammation | 1 | 2019 | 10873 | 0.160 |
Why?
|
Evolution, Molecular | 4 | 2014 | 1896 | 0.160 |
Why?
|
Neovascularization, Pathologic | 3 | 2008 | 2631 | 0.160 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2002 | 249 | 0.160 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2019 | 72 | 0.160 |
Why?
|
Cell Survival | 6 | 2018 | 5789 | 0.160 |
Why?
|
Cells, Cultured | 10 | 2018 | 19025 | 0.160 |
Why?
|
Estrogen Receptor Modulators | 1 | 2018 | 58 | 0.160 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1837 | 0.160 |
Why?
|
Co-Repressor Proteins | 1 | 2019 | 190 | 0.160 |
Why?
|
Vesicular Transport Proteins | 1 | 2021 | 377 | 0.150 |
Why?
|
Receptors, Progesterone | 2 | 2019 | 1160 | 0.150 |
Why?
|
Genetic Markers | 2 | 2013 | 2603 | 0.150 |
Why?
|
Cystatin A | 1 | 2017 | 6 | 0.150 |
Why?
|
Telomere | 1 | 2004 | 943 | 0.150 |
Why?
|
Carrier Proteins | 5 | 2013 | 4939 | 0.150 |
Why?
|
Reactive Oxygen Species | 7 | 2017 | 2152 | 0.150 |
Why?
|
Protein Binding | 6 | 2018 | 9343 | 0.150 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 116 | 0.150 |
Why?
|
Biological Evolution | 2 | 2017 | 1076 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11878 | 0.150 |
Why?
|
Drug Design | 3 | 2011 | 1046 | 0.150 |
Why?
|
Keratinocytes | 3 | 2013 | 876 | 0.150 |
Why?
|
Organ Specificity | 3 | 2015 | 1968 | 0.140 |
Why?
|
Cyclin D3 | 1 | 2017 | 54 | 0.140 |
Why?
|
Cluster Analysis | 6 | 2015 | 2732 | 0.140 |
Why?
|
Cyclin G1 | 1 | 2017 | 15 | 0.140 |
Why?
|
Amino Acid Sequence | 8 | 2003 | 13422 | 0.140 |
Why?
|
Mice, Knockout | 5 | 2024 | 14488 | 0.140 |
Why?
|
Cell Line | 14 | 2016 | 15602 | 0.140 |
Why?
|
Germ-Line Mutation | 3 | 2019 | 1885 | 0.140 |
Why?
|
Retinoblastoma Protein | 2 | 2020 | 671 | 0.140 |
Why?
|
DNA, Mitochondrial | 3 | 2017 | 872 | 0.140 |
Why?
|
Gene Dosage | 2 | 2018 | 1219 | 0.140 |
Why?
|
MicroRNAs | 4 | 2017 | 3803 | 0.130 |
Why?
|
Antigens, Neoplasm | 3 | 2019 | 1996 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2019 | 13586 | 0.130 |
Why?
|
Procollagen-Proline Dioxygenase | 2 | 2009 | 81 | 0.130 |
Why?
|
Flow Cytometry | 4 | 2017 | 5902 | 0.130 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2016 | 31 | 0.130 |
Why?
|
Fungal Proteins | 3 | 1994 | 906 | 0.130 |
Why?
|
Centrosome | 2 | 2014 | 210 | 0.130 |
Why?
|
Loss of Heterozygosity | 2 | 2008 | 663 | 0.130 |
Why?
|
Drug Synergism | 1 | 2020 | 1760 | 0.130 |
Why?
|
DNA Copy Number Variations | 2 | 2023 | 2048 | 0.130 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1752 | 0.130 |
Why?
|
Blotting, Western | 5 | 2013 | 5028 | 0.130 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2016 | 148 | 0.130 |
Why?
|
Phosphoserine | 1 | 2016 | 204 | 0.130 |
Why?
|
Blotting, Northern | 3 | 2002 | 1553 | 0.130 |
Why?
|
Dermcidins | 1 | 2015 | 1 | 0.120 |
Why?
|
Mitogens | 2 | 1995 | 229 | 0.120 |
Why?
|
Down-Regulation | 7 | 2009 | 2939 | 0.120 |
Why?
|
Casein Kinase II | 1 | 2016 | 121 | 0.120 |
Why?
|
Immune System | 1 | 2020 | 800 | 0.120 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3610 | 0.120 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11095 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 6 | 2006 | 4528 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 724 | 0.120 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2017 | 260 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 3517 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 752 | 0.120 |
Why?
|
Interleukin-11 | 1 | 2014 | 59 | 0.120 |
Why?
|
Forkhead Transcription Factors | 2 | 2014 | 1625 | 0.120 |
Why?
|
Binding, Competitive | 1 | 2016 | 1142 | 0.120 |
Why?
|
Lung | 3 | 2019 | 10101 | 0.110 |
Why?
|
RNA Editing | 1 | 2015 | 150 | 0.110 |
Why?
|
Animals, Genetically Modified | 1 | 2019 | 1563 | 0.110 |
Why?
|
Forecasting | 2 | 2016 | 2945 | 0.110 |
Why?
|
Biotechnology | 1 | 2016 | 283 | 0.110 |
Why?
|
Protein Phosphatase 2 | 1 | 2016 | 231 | 0.110 |
Why?
|
Amino Acid Transport System y+ | 1 | 2013 | 40 | 0.110 |
Why?
|
Genetic Testing | 3 | 2016 | 3591 | 0.110 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2014 | 131 | 0.110 |
Why?
|
Phosphorylation | 8 | 2017 | 8316 | 0.110 |
Why?
|
Adenosine Deaminase | 1 | 2015 | 253 | 0.110 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2013 | 110 | 0.110 |
Why?
|
Sexual Maturation | 1 | 2015 | 258 | 0.110 |
Why?
|
Mice, Nude | 3 | 2011 | 3623 | 0.110 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2013 | 95 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1596 | 0.100 |
Why?
|
DNA Repair | 4 | 2022 | 2050 | 0.100 |
Why?
|
Organogenesis | 1 | 2014 | 214 | 0.100 |
Why?
|
Methods | 2 | 2010 | 1066 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2014 | 334 | 0.100 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1703 | 0.100 |
Why?
|
Precancerous Conditions | 2 | 2017 | 985 | 0.100 |
Why?
|
Exons | 3 | 2011 | 2394 | 0.100 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2040 | 0.100 |
Why?
|
Protein Kinases | 3 | 1994 | 1611 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 7 | 2000 | 379 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2015 | 858 | 0.100 |
Why?
|
Databases, Genetic | 3 | 2010 | 1758 | 0.100 |
Why?
|
Oncogene Proteins, Viral | 1 | 2013 | 342 | 0.100 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 681 | 0.100 |
Why?
|
Societies, Scientific | 1 | 2012 | 223 | 0.090 |
Why?
|
Base Sequence | 8 | 2015 | 12422 | 0.090 |
Why?
|
Estradiol | 1 | 2018 | 1951 | 0.090 |
Why?
|
Research | 1 | 2020 | 1979 | 0.090 |
Why?
|
Bacteria | 1 | 2022 | 2216 | 0.090 |
Why?
|
Ki-67 Antigen | 2 | 2008 | 630 | 0.090 |
Why?
|
p21-Activated Kinases | 1 | 2011 | 127 | 0.090 |
Why?
|
Transplantation, Heterologous | 4 | 2013 | 2393 | 0.090 |
Why?
|
DNA Helicases | 1 | 2016 | 854 | 0.090 |
Why?
|
Receptor, erbB-3 | 1 | 2011 | 142 | 0.090 |
Why?
|
Treatment Outcome | 4 | 2024 | 65379 | 0.090 |
Why?
|
Glutamine | 1 | 2013 | 577 | 0.090 |
Why?
|
Antigens, Surface | 1 | 2015 | 1617 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2011 | 125 | 0.090 |
Why?
|
Isoenzymes | 2 | 2010 | 1688 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2000 | 4249 | 0.090 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 2006 | 432 | 0.090 |
Why?
|
Paracrine Communication | 2 | 2008 | 279 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 5 | 2013 | 5704 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2011 | 1246 | 0.090 |
Why?
|
Retinal Dehydrogenase | 1 | 2010 | 78 | 0.090 |
Why?
|
Immunophenotyping | 1 | 2015 | 1864 | 0.080 |
Why?
|
Doxorubicin | 2 | 2015 | 2234 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4648 | 0.080 |
Why?
|
Cyclin-Dependent Kinase 2 | 6 | 1995 | 185 | 0.080 |
Why?
|
Piperazines | 1 | 2020 | 2554 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2011 | 16044 | 0.080 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2010 | 146 | 0.080 |
Why?
|
HEK293 Cells | 1 | 2018 | 4280 | 0.080 |
Why?
|
RNA | 4 | 2024 | 2722 | 0.080 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 393 | 0.080 |
Why?
|
Genes, jun | 1 | 2008 | 69 | 0.080 |
Why?
|
Basement Membrane | 1 | 2010 | 348 | 0.080 |
Why?
|
Risk Factors | 7 | 2023 | 74944 | 0.080 |
Why?
|
Cathepsin K | 1 | 2008 | 65 | 0.080 |
Why?
|
Keratins | 1 | 2010 | 499 | 0.080 |
Why?
|
Advisory Committees | 1 | 2012 | 796 | 0.080 |
Why?
|
Receptors, IgE | 1 | 2010 | 375 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2894 | 0.070 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2010 | 452 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2015 | 1367 | 0.070 |
Why?
|
Expressed Sequence Tags | 2 | 2006 | 251 | 0.070 |
Why?
|
Pyrroles | 1 | 2014 | 1124 | 0.070 |
Why?
|
Protein Isoforms | 1 | 2013 | 1715 | 0.070 |
Why?
|
Mink | 4 | 1995 | 31 | 0.070 |
Why?
|
MAP Kinase Signaling System | 2 | 2011 | 1495 | 0.070 |
Why?
|
Cyclin D1 | 1 | 2009 | 453 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2011 | 564 | 0.070 |
Why?
|
Lymphatic Metastasis | 2 | 2014 | 2914 | 0.070 |
Why?
|
DNA Replication | 1 | 2014 | 1427 | 0.070 |
Why?
|
Psoriasis | 2 | 2008 | 926 | 0.070 |
Why?
|
Hyperplasia | 3 | 2002 | 1151 | 0.070 |
Why?
|
Nanoparticles | 2 | 2017 | 1986 | 0.070 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 771 | 0.070 |
Why?
|
Receptors, Notch | 1 | 2012 | 751 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2019 | 3080 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1536 | 0.070 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2009 | 319 | 0.070 |
Why?
|
Proteomics | 2 | 2016 | 3912 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1891 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2024 | 20225 | 0.070 |
Why?
|
Barrett Esophagus | 1 | 2010 | 495 | 0.070 |
Why?
|
Immunoblotting | 3 | 2009 | 1648 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9419 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1394 | 0.070 |
Why?
|
Aneuploidy | 2 | 2014 | 573 | 0.070 |
Why?
|
Receptors, Retinoic Acid | 2 | 2004 | 229 | 0.070 |
Why?
|
Aged | 8 | 2023 | 171502 | 0.070 |
Why?
|
Cell Adhesion | 2 | 2014 | 3097 | 0.060 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 250 | 0.060 |
Why?
|
Gene Knockout Techniques | 2 | 2022 | 806 | 0.060 |
Why?
|
Genome-Wide Association Study | 4 | 2017 | 12795 | 0.060 |
Why?
|
Genotype | 3 | 2014 | 13045 | 0.060 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2006 | 167 | 0.060 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2005 | 101 | 0.060 |
Why?
|
Collagenases | 1 | 2005 | 221 | 0.060 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2008 | 634 | 0.060 |
Why?
|
Calgranulin B | 1 | 2005 | 87 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2008 | 697 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2013 | 2131 | 0.060 |
Why?
|
Adult | 14 | 2021 | 223646 | 0.060 |
Why?
|
Dioxygenases | 2 | 2009 | 353 | 0.060 |
Why?
|
Maternal Exposure | 1 | 2012 | 1096 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1737 | 0.060 |
Why?
|
Tumor Burden | 3 | 2015 | 1906 | 0.060 |
Why?
|
Polymerase Chain Reaction | 5 | 2009 | 6082 | 0.060 |
Why?
|
Substrate Specificity | 1 | 2008 | 1751 | 0.060 |
Why?
|
Muscle Cells | 1 | 2005 | 195 | 0.060 |
Why?
|
Cell Count | 1 | 2008 | 1832 | 0.060 |
Why?
|
Phylogeny | 2 | 2002 | 2843 | 0.060 |
Why?
|
Genetic Association Studies | 2 | 2013 | 2744 | 0.060 |
Why?
|
Osteoclasts | 1 | 2008 | 713 | 0.060 |
Why?
|
Age of Onset | 2 | 2002 | 3346 | 0.060 |
Why?
|
Models, Genetic | 3 | 2011 | 3447 | 0.060 |
Why?
|
Sequence Alignment | 2 | 2001 | 2179 | 0.060 |
Why?
|
Premenopause | 2 | 2020 | 1039 | 0.060 |
Why?
|
Mice, SCID | 4 | 2011 | 2627 | 0.050 |
Why?
|
Algorithms | 5 | 2017 | 14164 | 0.050 |
Why?
|
RNA Interference | 3 | 2017 | 2832 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2004 | 176 | 0.050 |
Why?
|
Genomic Instability | 1 | 2008 | 716 | 0.050 |
Why?
|
Leukocytes | 1 | 2011 | 2034 | 0.050 |
Why?
|
Tissue Distribution | 3 | 2002 | 2300 | 0.050 |
Why?
|
Middle Aged | 13 | 2021 | 223487 | 0.050 |
Why?
|
Body Fluids | 1 | 2004 | 321 | 0.050 |
Why?
|
Growth Inhibitors | 2 | 2001 | 375 | 0.050 |
Why?
|
Microscopy, Atomic Force | 1 | 2023 | 250 | 0.050 |
Why?
|
Mitosis | 3 | 1997 | 1178 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1942 | 0.050 |
Why?
|
Uteroglobin | 1 | 2002 | 56 | 0.050 |
Why?
|
Chemokine CXCL12 | 1 | 2004 | 457 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2014 | 3474 | 0.050 |
Why?
|
Glomerulonephritis | 1 | 2024 | 333 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2012 | 9561 | 0.050 |
Why?
|
Mechanical Phenomena | 1 | 2023 | 143 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15453 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2005 | 1989 | 0.050 |
Why?
|
In Situ Hybridization | 2 | 2004 | 1904 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2022 | 1613 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2013 | 1640 | 0.050 |
Why?
|
Elasticity | 1 | 2023 | 657 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2002 | 525 | 0.050 |
Why?
|
Response Elements | 1 | 2002 | 308 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2043 | 0.050 |
Why?
|
DNA Mutational Analysis | 4 | 2012 | 4120 | 0.040 |
Why?
|
Penetrance | 1 | 2002 | 385 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2004 | 931 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2010 | 1668 | 0.040 |
Why?
|
Histidine | 1 | 2000 | 301 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2010 | 8542 | 0.040 |
Why?
|
Autoantibodies | 1 | 2008 | 2121 | 0.040 |
Why?
|
Adenocarcinoma | 2 | 2010 | 6395 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1519 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2000 | 766 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2002 | 838 | 0.040 |
Why?
|
Oxidative Stress | 3 | 2017 | 3140 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2017 | 3670 | 0.040 |
Why?
|
Cricetulus | 1 | 2001 | 812 | 0.040 |
Why?
|
COS Cells | 1 | 2001 | 1135 | 0.040 |
Why?
|
Spheroids, Cellular | 2 | 2013 | 331 | 0.040 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2237 | 0.040 |
Why?
|
Tretinoin | 1 | 2002 | 525 | 0.040 |
Why?
|
Collagen | 2 | 2023 | 2645 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 1406 | 0.040 |
Why?
|
Homeostasis | 2 | 2008 | 3348 | 0.040 |
Why?
|
CHO Cells | 1 | 2001 | 1379 | 0.040 |
Why?
|
Membrane Proteins | 3 | 2012 | 7876 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 2011 | 866 | 0.040 |
Why?
|
Proteome | 1 | 2008 | 1890 | 0.040 |
Why?
|
Polyenes | 2 | 1994 | 68 | 0.040 |
Why?
|
Adenoviridae | 1 | 2002 | 1093 | 0.040 |
Why?
|
Bronchi | 1 | 2002 | 850 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18415 | 0.040 |
Why?
|
Ecological and Environmental Phenomena | 1 | 2017 | 10 | 0.040 |
Why?
|
Exonucleases | 1 | 1997 | 42 | 0.040 |
Why?
|
Phosphofructokinase-1 | 1 | 2017 | 50 | 0.040 |
Why?
|
Cathepsin B | 1 | 2017 | 80 | 0.040 |
Why?
|
Cricetinae | 1 | 2001 | 2423 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59626 | 0.040 |
Why?
|
G2 Phase | 1 | 1997 | 135 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 2819 | 0.040 |
Why?
|
Reactive Nitrogen Species | 1 | 2017 | 35 | 0.040 |
Why?
|
Pancreas | 1 | 2004 | 1699 | 0.040 |
Why?
|
Antioxidants | 1 | 2005 | 1676 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1767 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2005 | 2414 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2017 | 185 | 0.040 |
Why?
|
Cytoplasm | 1 | 2002 | 1505 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 22290 | 0.030 |
Why?
|
Arginine | 1 | 2000 | 932 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2005 | 2709 | 0.030 |
Why?
|
Pentose Phosphate Pathway | 1 | 2017 | 126 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2065 | 0.030 |
Why?
|
Thiazoles | 1 | 2024 | 1542 | 0.030 |
Why?
|
Acetaldehyde | 1 | 2016 | 39 | 0.030 |
Why?
|
Gigantism | 1 | 1996 | 15 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 1997 | 367 | 0.030 |
Why?
|
Alleles | 3 | 2007 | 6894 | 0.030 |
Why?
|
Male | 11 | 2022 | 364731 | 0.030 |
Why?
|
Prostate | 1 | 2004 | 1765 | 0.030 |
Why?
|
Medical Oncology | 1 | 2008 | 2346 | 0.030 |
Why?
|
DNA Primers | 3 | 2009 | 2828 | 0.030 |
Why?
|
Polyadenylation | 1 | 2016 | 114 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 2017 | 191 | 0.030 |
Why?
|
Computational Biology | 3 | 2013 | 3567 | 0.030 |
Why?
|
RNA, Satellite | 1 | 2014 | 16 | 0.030 |
Why?
|
Time Factors | 5 | 2017 | 40220 | 0.030 |
Why?
|
Gene Silencing | 1 | 2001 | 1505 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 515 | 0.030 |
Why?
|
Contact Inhibition | 1 | 1994 | 46 | 0.030 |
Why?
|
Formaldehyde | 1 | 2016 | 361 | 0.030 |
Why?
|
Adenomatous Polyposis Coli | 1 | 1996 | 219 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2017 | 1769 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 24318 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 229 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 1078 | 0.030 |
Why?
|
Cyclin D2 | 2 | 2004 | 98 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2014 | 191 | 0.030 |
Why?
|
Internet | 2 | 2003 | 3110 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 1999 | 1327 | 0.030 |
Why?
|
Mitochondria | 2 | 2017 | 3683 | 0.030 |
Why?
|
Sequence Analysis | 1 | 1994 | 240 | 0.030 |
Why?
|
Purines | 1 | 2017 | 615 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1995 | 306 | 0.030 |
Why?
|
Ovarian Neoplasms | 2 | 2008 | 4916 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 384 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2014 | 163 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 2007 | 4620 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 579 | 0.030 |
Why?
|
Serine | 1 | 2017 | 831 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 1999 | 4168 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 580 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 837 | 0.030 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2014 | 246 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3740 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10397 | 0.030 |
Why?
|
Core Binding Factor beta Subunit | 1 | 2012 | 42 | 0.030 |
Why?
|
Lysine | 1 | 2017 | 1000 | 0.020 |
Why?
|
Enzyme Inhibitors | 3 | 1997 | 3728 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1995 | 710 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2005 | 3589 | 0.020 |
Why?
|
Cell Transformation, Viral | 1 | 2013 | 530 | 0.020 |
Why?
|
Steroids | 1 | 2017 | 938 | 0.020 |
Why?
|
Interferon Type I | 1 | 2015 | 569 | 0.020 |
Why?
|
Vietnam | 1 | 2012 | 415 | 0.020 |
Why?
|
Human papillomavirus 16 | 1 | 2013 | 268 | 0.020 |
Why?
|
Colonic Polyps | 1 | 1996 | 557 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1997 | 2227 | 0.020 |
Why?
|
Cell Separation | 1 | 2017 | 1728 | 0.020 |
Why?
|
Adiposity | 1 | 2021 | 1895 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2013 | 435 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2017 | 1676 | 0.020 |
Why?
|
Glutathione | 1 | 2013 | 589 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4793 | 0.020 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2010 | 110 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1994 | 1470 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 467 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2013 | 899 | 0.020 |
Why?
|
Genetics | 1 | 2011 | 114 | 0.020 |
Why?
|
Nurses | 1 | 2020 | 2501 | 0.020 |
Why?
|
Infertility, Female | 1 | 1996 | 763 | 0.020 |
Why?
|
Cisplatin | 1 | 2016 | 1660 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 355 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 769 | 0.020 |
Why?
|
Binding Sites | 2 | 2015 | 6019 | 0.020 |
Why?
|
Trans-Activators | 1 | 1999 | 2857 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 998 | 0.020 |
Why?
|
Chromogenic Compounds | 1 | 2009 | 30 | 0.020 |
Why?
|
Speech | 1 | 2014 | 557 | 0.020 |
Why?
|
Pancreatic Neoplasms | 2 | 2004 | 5442 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 65 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 369 | 0.020 |
Why?
|
Gene Fusion | 1 | 2012 | 356 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1040 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 1247 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2017 | 3573 | 0.020 |
Why?
|
Benchmarking | 1 | 2015 | 1057 | 0.020 |
Why?
|
Ultraviolet Therapy | 1 | 2008 | 82 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2010 | 558 | 0.020 |
Why?
|
Microtubules | 1 | 2014 | 1064 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39354 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6847 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2010 | 384 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 874 | 0.020 |
Why?
|
Microdissection | 1 | 2008 | 150 | 0.020 |
Why?
|
Codon | 1 | 2009 | 599 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1994 | 1895 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2798 | 0.020 |
Why?
|
Quantum Dots | 1 | 2009 | 168 | 0.020 |
Why?
|
Fibrocystic Breast Disease | 1 | 2008 | 103 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1996 | 1322 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2008 | 348 | 0.020 |
Why?
|
Internationality | 1 | 2012 | 1008 | 0.020 |
Why?
|
Paraffin Embedding | 1 | 2008 | 306 | 0.020 |
Why?
|
Chemokine CCL5 | 1 | 2007 | 214 | 0.020 |
Why?
|
Cohort Studies | 1 | 2010 | 41753 | 0.020 |
Why?
|
Genome | 2 | 2007 | 1754 | 0.020 |
Why?
|
Connective Tissue | 1 | 2009 | 425 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2007 | 286 | 0.020 |
Why?
|
Laminin | 1 | 2008 | 405 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2709 | 0.020 |
Why?
|
Adipocytes | 1 | 2013 | 1199 | 0.020 |
Why?
|
Osteolysis | 1 | 2008 | 274 | 0.020 |
Why?
|
Reference Values | 2 | 2003 | 4939 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2892 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2007 | 491 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1996 | 3044 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9613 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2008 | 705 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14729 | 0.010 |
Why?
|
Proteoglycans | 1 | 2008 | 809 | 0.010 |
Why?
|
Drug Discovery | 1 | 2012 | 1068 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 615 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1972 | 0.010 |
Why?
|
Acetylcysteine | 1 | 2005 | 262 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12840 | 0.010 |
Why?
|
Chromosomes, Human, Y | 1 | 2005 | 164 | 0.010 |
Why?
|
Databases, Factual | 1 | 1999 | 8080 | 0.010 |
Why?
|
Tyrosine | 1 | 2008 | 1427 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4064 | 0.010 |
Why?
|
HeLa Cells | 1 | 2009 | 3074 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 89169 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2674 | 0.010 |
Why?
|
DNA | 1 | 2017 | 7213 | 0.010 |
Why?
|
Software | 2 | 2007 | 4480 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 800 | 0.010 |
Why?
|
Chromosomes, Human, X | 1 | 2005 | 320 | 0.010 |
Why?
|
Mammaplasty | 1 | 2013 | 1269 | 0.010 |
Why?
|
Consensus | 1 | 2012 | 3211 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1599 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2010 | 2359 | 0.010 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2007 | 507 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1667 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6229 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10099 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 1994 | 4206 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11101 | 0.010 |
Why?
|
Drug Combinations | 1 | 2008 | 2089 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3814 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 22380 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2010 | 2062 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2007 | 2357 | 0.010 |
Why?
|
Multigene Family | 1 | 2003 | 1081 | 0.010 |
Why?
|
Colonic Neoplasms | 2 | 2003 | 2541 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2009 | 2059 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6525 | 0.010 |
Why?
|
Genetics, Medical | 1 | 2002 | 334 | 0.010 |
Why?
|
Artifacts | 1 | 2008 | 1926 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 13091 | 0.010 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 1999 | 182 | 0.010 |
Why?
|
DNA, Satellite | 1 | 1998 | 67 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2000 | 362 | 0.010 |
Why?
|
Exoribonucleases | 1 | 1997 | 88 | 0.010 |
Why?
|
Sirolimus | 2 | 1994 | 1540 | 0.010 |
Why?
|
Polyploidy | 1 | 1997 | 120 | 0.010 |
Why?
|
14-3-3 Proteins | 1 | 1997 | 221 | 0.010 |
Why?
|
Eukaryotic Cells | 1 | 1997 | 192 | 0.010 |
Why?
|
Thymus Hyperplasia | 1 | 1996 | 32 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1995 | 76 | 0.010 |
Why?
|
Mastectomy | 1 | 2004 | 1862 | 0.010 |
Why?
|
MutS Homolog 2 Protein | 1 | 1996 | 200 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7454 | 0.010 |
Why?
|
Threonine | 1 | 1995 | 273 | 0.010 |
Why?
|
Glioma | 1 | 2009 | 3503 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1994 | 260 | 0.010 |
Why?
|
Regression Analysis | 1 | 2004 | 6340 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 60066 | 0.010 |
Why?
|
beta Catenin | 1 | 1999 | 1047 | 0.010 |
Why?
|
Allosteric Regulation | 1 | 1995 | 426 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1994 | 816 | 0.010 |
Why?
|
Computer Graphics | 1 | 1995 | 344 | 0.010 |
Why?
|
Mammography | 1 | 2004 | 2433 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 481 | 0.010 |
Why?
|
Cell Extracts | 1 | 1993 | 135 | 0.010 |
Why?
|
Antigen-Antibody Complex | 1 | 1994 | 513 | 0.010 |
Why?
|
Gene Targeting | 1 | 1996 | 841 | 0.010 |
Why?
|
Child | 1 | 2021 | 80917 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2004 | 2565 | 0.010 |
Why?
|
Protein Folding | 1 | 1995 | 871 | 0.010 |
Why?
|
United States | 2 | 2012 | 73039 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 1995 | 1951 | 0.010 |
Why?
|
Syndrome | 1 | 1996 | 3273 | 0.010 |
Why?
|
Esophagus | 1 | 1996 | 1042 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1995 | 2004 | 0.000 |
Why?
|
Colon | 1 | 1996 | 1801 | 0.000 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 1998 | 2909 | 0.000 |
Why?
|
Protein Conformation | 1 | 1995 | 3956 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1996 | 6231 | 0.000 |
Why?
|
Prevalence | 1 | 2004 | 15869 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6512 | 0.000 |
Why?
|
Adenoma | 1 | 1996 | 2159 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1996 | 5505 | 0.000 |
Why?
|
Glioblastoma | 1 | 1999 | 3464 | 0.000 |
Why?
|
Escherichia coli | 1 | 1995 | 4213 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1996 | 9262 | 0.000 |
Why?
|
Brain | 1 | 1999 | 27362 | 0.000 |
Why?
|